External quality assessment providers' services appear to more impact the immunohaematology performance of laboratories than national regulatory and economic conditions.
Buchta C, Coucke W, Huf W, Griesmacher A, Müller MM, Mayr WR, Flesland Ø, Politis C, Wiersum-Osselton J, Aburto A, Badrick T, Bouacida L, Budina M, Duenas JA, Geilenkeuser WJ, Guimarães AVP, Hecimovic A, Jutzi M, Lee CK, Lim YA, Mammen J, Molnár PM, Mokhtari A, Morabito G, Muñiz-Diaz E, Niekerk T, Pakkanen A, Pezzati P, Popa R, Sárkány E, Siest JP, Suvagandha D, Thelen M, Ullhagen J, Vitkus D, Körmöczi GF.
Buchta C, et al. Among authors: flesland o.
Clin Chem Lab Med. 2022 Jan 19;60(3):361-369. doi: 10.1515/cclm-2021-1219. Print 2022 Feb 23.
Clin Chem Lab Med. 2022.
PMID: 35041777